His primary areas of investigation include Genetics, Immunology, Internal medicine, Cancer research and Molecular biology. His studies deal with areas such as Haematopoiesis, Stem cell and Transplantation as well as Immunology. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Oncology.
His Cancer research research includes themes of Germline mutation, X-linked severe combined immunodeficiency, Gene knockdown, microRNA and Regulation of gene expression. He combines subjects such as Drosophila melanogaster, Neoplasm genetics, Genome and Lymphoma with his study of microRNA. His work deals with themes such as RNA, Protein family, Myeloid leukemia, Exon and breakpoint cluster region, which intersect with Molecular biology.
Arndt Borkhardt mostly deals with Cancer research, Immunology, Leukemia, Internal medicine and Molecular biology. His biological study spans a wide range of topics, including Cell culture, Haematopoiesis, microRNA and T cell. He has included themes like Cancer, Myeloid leukemia, Immunophenotyping and Chromosomal translocation in his Leukemia study.
His research in Internal medicine intersects with topics in Gastroenterology, Surgery and Oncology. The concepts of his Molecular biology study are interwoven with issues in Genetics, Gene, DNA and Polymerase chain reaction. His research in Genetics is mostly concerned with Germline.
Arndt Borkhardt spends much of his time researching Cancer research, Internal medicine, Leukemia, Oncology and Medulloblastoma. His Cancer research research is multidisciplinary, incorporating perspectives in Cell culture, T cell, Text mining, Chemokine and Immunotherapy. His study in Internal medicine is interdisciplinary in nature, drawing from both Pearson syndrome and Drug.
His Leukemia study is concerned with Immunology in general. His Oncology research incorporates themes from Hematopoietic stem cell transplantation, Disease, Clinical trial, Incidence and Minimal residual disease. His Chromothripsis research is multidisciplinary, relying on both Genome and Germline.
Arndt Borkhardt mainly investigates Cancer research, Oncology, Internal medicine, Germline and Lymphoblastic Leukemia. His Cancer research study incorporates themes from Cancer stem cell, microRNA and B cell. His Germline study combines topics in areas such as Genome and Whole genome sequencing.
Genetics and Gene are all intrinsically tied to his study in Whole genome sequencing. Arndt Borkhardt works mostly in the field of Lymphoblastic Leukemia, limiting it down to topics relating to Side effect and, in certain cases, Leukemia, as a part of the same area of interest. His research investigates the connection between Gene expression profiling and topics such as Ex vivo that intersect with issues in Regulation of gene expression.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A mammalian microRNA expression atlas based on small RNA library sequencing.
Pablo Landgraf;Mirabela Rusu;Robert Sheridan;Alain Sewer;Alain Sewer.
Cell (2007)
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Salima Hacein-Bey-Abina;Alexandrine Garrigue;Gary P. Wang;Jean Soulier.
Journal of Clinical Investigation (2008)
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
(2020)
New microRNAs from mouse and human
Mariana Lagos-Quintana;Reinhard Rauhut;Jutta Meyer;Arndt Borkhardt.
RNA (2003)
The landscape of genomic alterations across childhood cancers
Susanne N. Gröbner;Barbara C. Worst;Joachim Weischenfeldt;Joachim Weischenfeldt;Ivo Buchhalter.
Nature (2018)
High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma.
Markus Metzler;Monika Wilda;Kerstin Busch;Susanne Viehmann.
Genes, Chromosomes and Cancer (2004)
Backtracking leukemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spots
Karin B. Gale;Anthony M. Ford;Reinald Repp;Arndt Borkhardt.
Proceedings of the National Academy of Sciences of the United States of America (1997)
Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi).
Monika Wilda;Uta Fuchs;Wilhelm Wössmann;Arndt Borkhardt.
Oncogene (2002)
Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy.
Thomas Tuschl;Arndt Borkhardt.
Molecular Interventions (2002)
Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
Arend von Stackelberg;Franco Locatelli;Gerhard Zugmaier;Rupert Handgretinger.
Journal of Clinical Oncology (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Giessen
Kiel University
Heinrich Heine University Düsseldorf
Community College of Rhode Island
Goethe University Frankfurt
Tel Aviv University
Goethe University Frankfurt
German Cancer Research Center
University of Salamanca
Charité - University Medicine Berlin
University of Minnesota
New Jersey Institute of Technology
Nanyang Technological University
University of Bari Aldo Moro
Kobe University
University of Sydney
University of Duisburg-Essen
Max Planck Society
University of Tsukuba
University of Colorado Anschutz Medical Campus
University of Basel
Lehigh University
Indiana University
University of East Anglia
Johns Hopkins University
University of Tokyo